BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 571836)

  • 1. Clinical use of metoclopramide test in the diagnosis of women with hyperprolactinemia.
    Vázquez-Matute L; Canales ES; Alger M; Zárate A
    Horm Res; 1979; 10(4):207-12. PubMed ID: 571836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
    MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
    Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia and galactorrhea: spontaneous versus iatrogenic hypothyroidism.
    Contreras P; Generini G; Michelsen H; Pumarino H; Campino C
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1036-9. PubMed ID: 7197286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
    Jeske W
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
    De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
    Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome.
    Tucker HS; Lankford HV; Gardner DF; Blackard WG
    J Clin Endocrinol Metab; 1980 Nov; 51(5):968-71. PubMed ID: 6775003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A; De Marinis L; Maira G; Menini E; Anile C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and endocrinological analyses of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide.
    Aono T; Shioji T; Kinugasa T; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1978 Sep; 47(3):675-80. PubMed ID: 122411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea.
    Aono T; Shioji T; Miyai K; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1977 Jan; 44(1):8-14. PubMed ID: 401825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G; Chernova T; Goncharov N
    Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia and associated pituitary prolactinomas.
    Brenner SH; Lessing JB; Quagliarello J; Weiss G
    Obstet Gynecol; 1985 May; 65(5):661-4. PubMed ID: 4039046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
    Seki K; Uesato T; Kato K; Shima K
    Endocrinol Jpn; 1984 Dec; 31(6):733-9. PubMed ID: 6532792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional delineation of hyperprolactinemic-amenorrhea.
    Lachelin GC; Abu-fadil S; Yen SS
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1163-74. PubMed ID: 406271
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.
    Sowers JR; Carlson HE; Brautbar N; Hershman JM
    J Clin Endocrinol Metab; 1977 Feb; 44(2):237-41. PubMed ID: 402375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
    Andersen AN; Tabor A
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pituitary function in patients with serum prolactin levels greater than 100 ng/ml.
    Blackwell RE; Boots LR; Goldenberg RL; Younger JB
    Fertil Steril; 1979 Aug; 32(2):177-82. PubMed ID: 572785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
    Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.